Sonlicromanol’s Active Metabolite KH176m Normalizes Prostate Cancer Stem Cell mPGES-1 Overexpression and Inhibits Cancer Spheroid Growth

Investigators investigated whether KH176m, a recently discovered selective mPGES-1 inhibitor, could affect prostate cancer cells-derived spheroid growth.